Aurobindo, Hetero, and Vivimed Class Action Settlements in Alabama
Aurobindo, Hetero, and Vivimed class action settlements that covered Alabama residents — and where each one now stands.
Last checked: August 11, 2026 · By Class Action Buddy
Alabama residents have no confirmed open class action settlements involving Aurobindo, Hetero, and Vivimed right now. The Aurobindo, Hetero, and Vivimed settlement below has closed — the claim deadline has passed and no new claims can be filed. If you are looking for something you can still claim, our list of open settlements is checked against each administrator.
Class Action Buddy fills in official claim forms from your saved profile in under 60 seconds, then prints and posts the completed claim for you. There is nothing to file against Aurobindo, Hetero, and Vivimed at the moment — see what is open now.
Closed Aurobindo, Hetero, and Vivimed Settlements for Alabama Residents (1)
This Aurobindo, Hetero, and Vivimed settlement is no longer accepting claims. It closed on the date shown and the deadline cannot be reopened. It is listed here because the settlement and its administrator are a matter of record and people still search for it. For settlements that are open today, see our list of open settlements.
$15.2M Valsartan, Losartan and Irbesartan class action settlement
Up to TBDFile your claim for the $15.2M Valsartan, Losartan, and Irbesartan settlement. Blood pressure medication contaminated with cancer-causing substances.
About Aurobindo, Hetero, and Vivimed Class Actions in Alabama
Before you read on: the Aurobindo, Hetero, and Vivimed settlement described below has closed. This section explains what it was about and who was covered, which is still worth knowing — but it cannot be claimed now. See settlements that are open today.
Alabama residents affected by contaminated blood pressure medications manufactured by Aurobindo, Hetero, and Vivimed may be eligible for compensation through the $15.2 million class action settlement covering Valsartan, Losartan, and Irbesartan products. Alabama's Deceptive Trade Practices Act provides additional consumer protection for residents who purchased defective pharmaceuticals, potentially strengthening claims against these manufacturers. While these companies don't maintain major manufacturing facilities in Alabama, their generic medications are widely distributed through Alabama pharmacies and healthcare systems, including those serving Birmingham, Mobile, and Huntsville metro areas. Alabama follows federal court procedures for multi-district litigation, meaning residents' claims are typically consolidated with cases from other states in federal court rather than state court. The contamination involved NDMA and other carcinogenic impurities discovered in these widely-prescribed blood pressure medications between 2018-2020. Alabama residents who took these medications during the contamination period should preserve pharmacy records and medical documentation to support their claims, as the state's four-year statute of limitations for product liability claims may apply to individual cases outside the class action framework.
Aurobindo, Hetero, and Vivimed Settlements in Alabama: FAQs
Are Alabama residents eligible for the Aurobindo, Hetero, and Vivimed blood pressure medication settlement?
Yes, Alabama residents who took contaminated Valsartan, Losartan, or Irbesartan manufactured by these companies are eligible for the $15.2 million class action settlement. You must have purchased and consumed these medications during the contamination period between 2018-2020 to qualify for compensation.
How does Alabama's statute of limitations affect claims against these pharmaceutical companies?
Alabama's four-year statute of limitations for product liability claims runs from when you discovered or should have discovered the contamination. However, the class action settlement has specific deadlines that may be shorter than Alabama's statutory period. It's important to file your claim before the court-imposed deadline rather than relying on state statute timeframes.
Can Alabama residents file individual lawsuits against Aurobindo, Hetero, and Vivimed outside the class action?
Alabama residents can opt out of the class action settlement to pursue individual claims under Alabama's product liability laws. However, you must formally opt out within the specified timeframe and consider that individual litigation involves higher costs and uncertain outcomes compared to the guaranteed settlement amounts.
Tips for Alabama Residents Filing Aurobindo, Hetero, and Vivimed Claims
Alabama residents filing claims should gather pharmacy records showing purchases of contaminated Valsartan, Losartan, or Irbesartan from Aurobindo, Hetero, and Vivimed between 2018-2020. Contact your pharmacy for detailed prescription histories if you don't have receipts. Medical records documenting your blood pressure treatment during this period strengthen your claim. File claims before court deadlines, which are typically shorter than Alabama's four-year statute of limitations. Consider consulting Alabama attorneys familiar with pharmaceutical litigation if you experienced significant health complications. Keep copies of all documentation submitted, as Alabama's consumer protection laws may provide additional remedies beyond the federal class action settlement for residents who suffered substantial damages.
File Aurobindo, Hetero, and Vivimed Claims in 60 Seconds
Class Action Buddy auto-fills your claim forms and submits them electronically. Your first claim is free.
